The pluripotency and high proliferative capacity of embryonic stem (ES) cells (1-3) makes them an attractive source of different cell types for biomedical research and cell replacement therapies. A major prerequisite for these applications is the availability of a homogeneous population of the desired cell type. However, ES cell-derived material contains, for example, undifferentiated cells, which can cause tumor formation after transplantation into the brain (4). To avoid such unwanted side effects, effective purification of distinct types of cells needs to be developed. Here, we describe an immunoisolation procedure to purify neurons from in vitro differentiated mouse ES cells using an antibody against the neuronal cell adhesion molecule L1 (5, 6). Our procedure yields a pure population of differentiated neurons, which are electrically excitable and form excitatory, glutamatergic, and inhibitory GABAergic synapses. The ability to highly purify ES cell-derived neurons will boost their molecular characterization and the further exploration of their therapeutic potential.
luripotent embryonic stem (ES) cells derived from the inner cell mass of mammalian blastocysts provide a largely unlimited source of cells that can potentially differentiate into all known cell types (1) (2) (3) . In vitro differentiation of ES cells within embryoid bodies (EBs) can be partly controlled by specific cultivation protocols to yield preferentially a certain cell type, for example, neurons (7) (8) (9) (10) . However, in vitro differentiation produces heterogeneous cell populations and does not lead to the desired pure population of a single cell type. Therefore, the potential use of ES cell-derived neurons in cell replacement therapies of neurodegenerative diseases requires a purification step to eliminate nonneuronal and undifferentiated cells, because such unwanted cells might give rise to tumor formation, for example.
Current approaches to purify neurons or neural precursor cells from in vitro differentiated ES cells involve genetic engineering of mouse ES cells to either introduce a fluorescent marker protein or a resistance to antibiotics. The introduction of green fluorescent protein (GFP) fused to tau-protein by gene targeting has been used to isolate tau-expressing neurons by fluorescenceactivated cell sorting (11) . An alternative genetic approach to purify neural precursor cells used P lineage selection that was based on the targeted integration of the selection marker βgeo into the sox2 gene (12) . However, the above methods all require genetic modification of ES cells, making such cell lines poor candidates for therapeutic transplantation.
An attractive alternative to the use of genetically modified ES cells is to purify neurons by detecting endogenous, neuron-specific cell surface molecules (13, 14) . For example, isolation of retinal ganglion cells from dissociated retinae by binding to an immobilized, RGC-specific antibody (immunopanning) has been developed (13, 15) . In this paper, we describe a purification procedure for ES cell-derived neurons based on the neuron-specific expression of the cell adhesion molecule L1. We have developed a one-step immunoisolation technique that allows us to highly purify neurons from dissociated embryoid bodies using specific binding to L1-antibodies.
MATERIALS AND METHODS

ES cell culture and in vitro differentiation of EBs
Proliferating mouse ES cells (line R1: gift of Dr. Zhu, Dept. Animal Physiology, RuhrUniversität Bochum, Germany; line D3: gift of Dr. Fleischmann, Dept. Neurophysiology, Universität Köln, Germany) were cultured on mouse embryonic feeder cells (inactivated with mitomycin-C) in the presence of LIF (Chemicon, Temecula, CA) according to standard protocols (16) . EB formation was done in hanging drops according to Strübing et al. (7) except for a higher inital density of ES cells (8000/10 µl). In vitro differentiation of ES cells to neurons was promoted by addition of retinoic acid (0.5 µM) for 6 days (3 days in hanging drops and 3 days in suspension culture). EBs were further cultured for 2 wk in the absence of retinoic acid on polyornithine-coated dishes at 37°C in 5% CO 2 atmosphere (Neurobasal medium with addition of B27 supplement, glutamax, and penicillin/streptomycin [Invitrogen, Karlsruhe, Germany)]).
EB dissociation and L1-immunoisolation
For L1-immunoisolation, a plastic petri dish was coated with a goat anti-rat IgG (80 µl antibody [1.3 mg/ml] in 10 ml Tris/HCl pH 9.5 [Jackson Immunoresearch Laboratories, West Grove, PA]) for 24 h at 4°C. After it was rinsed with PBS, the dish was incubated with bovine serum albumin (BSA) solution (0.2% in phosphate-buffered saline [PBS]) followed by addition of supernatant from a rat anti-L1 antibody producing hybridoma cell line (1:1 diluted in 0.2% BSA in PBS, final antibody concentration 1 µg/ml) (5). After the antibody-coated dish was incubated overnight at 4°C and rinsed with PBS, it was used for immunoisolation.
For dissociation, EBs were incubated for 50 min at 37°C in 10 ml EBSS medium (Invitrogen; with addition of 1.5 mM CaCl 2 , 1 mM EDTA, and 1 mM MgSO 4 ) with 120 µl papain (650 U/ml [Worthington, Cell Systems, St. Katharinen, Germany]) and 200 µl DNaseI (1 mg/ml; Sigma, Munich, Germany)) added. Then, EBs were rinsed with 4 ml 0.15% trypsin inhibitor/ovomucoid (Roche, Mannheim, Germany) in PBS and were mechanically dissociated in 0.15% trypsin inhibitor/ovomucoid in PBS plus DNaseI. After centrifugation, cells were resuspended in 1% trypsin inhibitor/ovomucoid in PBS. After another centrifugation step, cells were resuspended in bovine serum albumin (BSA) (0.02% in PBS) and added to the L1-coated petri dish. Immunoisolation was performed at room temperature for 1.5 h. Then, nonadherent cells were washed off with PBS. Adherent cells were harvested using trypsin/EDTA (Invitrogen) for 10 min at 37°C and were suspended in 25% fetal bovine serum (FBS) in PBS to block trypsinization. Cells were spun down and resuspended in neurobasal medium.
Cell culture of L1-selected cells
All cultures were incubated at 37°C in 5% CO 2 atmosphere. L1-selected cells were short-term cultured for 2 days on poly-D-lysine (0.1 mg/ml) and laminin (10 ng/ml in NB + medium) coated culture dishes in a defined medium (NB + ) consisting of neurobasal medium (Invitrogen) with addition of supplements (17) . Propidiumiodide (1 µg/ml in PBS) was used to stain the nuclei of disrupted cells. For long-term cultures, L1-selected cells were seeded on glial cells in a microisland culture system (18) . Glial cells were obtained by mechanical dissociation of the cortex of perinatal C57/black6 mice after trypsin treatment and were cultured for several weeks in serum-containing medium (BME + : Eagle's basal medium (Invitrogen) with addition of insulin, glutamine, glucose, and 10% FBS) (19) . To prepare glial microislands, we incubated confluent glial cells in trypsin/EDTA, dissociated to single cells, and seeded at low density on uncoated glass coverslips in BME + medium with addition of cytosine-β-D-arabinofuranoside (10 µM) to inhibit proliferation. L1-selected cells were seeded on these glial microcultures at a density of 80-100 × 10 3 cells/35 mm 2 dish and were cultured in neurobasal medium with addition of B27 supplement, glutamax, and penicillin/streptomycin, leading to the formation of small networks of <10 neurons per glial microisland.
Immunocytochemistry
Immunocytochemistry was performed following standard protocols (19) . Nuclei were stained with Hoechst 33342 after incubation with primary antibody. Primary antibodies included rabbit anti-neurofilament 200 (Sigma), rabbit anti-GFAP (Chemicon), rabbit anti-fibronectin (Sigma), mouse anti-O4 (Chemicon), and rabbit anti-SynapsinI (Chemicon). Appropriate secondary antibodies were Cy2-or Cy3-conjugated (Chemicon).
Electrophysiology and data analysis
Somatic whole-cell patch-clamp recordings were performed at room temperature using an EPC7 patch-clamp amplifier (HEKA) as previously described (19) . Patch pipette solution consisted of (in mM) 110 KCl, 0.25 CaCl 2 , 10 EGTA, and 20 HEPES, pH 7.3. Extracellular solution consisted of (in mM) 130 NaCl, 5 KCl, 2.5 CaCl 2 , 1 MgCl 2 , and 20 HEPES, pH 7.3. Action potentials were elicited by depolarizing current pulses from a membrane potential of -70 mV in current-clamp mode. Miniature PSCs were recorded under voltage-clamp at -60 mV with increased KCl (30 mM), increased CaCl 2 (5 mM), and TTX (1 µM) in the extracellular solution. Pharmacological isolation of GABA A and non-NMDA PSCs was done with 10 µM DNQX and 1 mM Mg 2+ and with 100 µM picrotoxin and 1 mM Mg
2+
, respectively. Evoked PSCs were elicited by current injection in the presynaptic cell after establishment of paired recordings. NMDA receptor-mediated PSC components were recorded at +40 mV holding potential with K + channels blocked in the presence of picrotoxin (100 µM) and Mg 2+ (1 mM). Intracellular solution consisted of (in mM) 100 CsCl, 20 TEA-Cl, 0.25 CaCl 2 , 10 EGTA, and 20 HEPES, pH 7.3. Data analysis was done as previously described (19) .
RESULTS AND DISCUSSION
Neuronal differentiation of mouse ES cells within EBs was induced by retinoic acid according to standard protocols (7, 8) (Fig. 1A) . To obtain a cell suspension, we enzymatically and mechanically dissociated EBs to single cells. This cell suspension was subjected to an immunoisolation step using a L1-specific monoclonal antibody (5). During immunoisolation, L1-expressing cells adhered to an antibody-coated dish. To determine the cell yield of the immunoisolation procedure, we counted the number of cells selected by the L1-antibody and the total number of cells present in the cell suspension (Fig. 1B) . In 13 independent experiments, the mean fraction of adherent cells was 3.7 ± 0.01% (10 6 
cells). This indicates a robust selection of cells by the immunoisolation procedure.
To study the properties of the selected cells, we short-term cultured them in defined NB + medium on poly-D-lysine-and laminin-coated culture dishes. After 2 days in vitro (DIV), the majority of cells showed a typical neuronal morphology with elaborated neuritic processes (Fig.  2B) . We determined the viability of these cells using propidium iodide, a hydrophilic nuclear acid stain that can enter only into cells with disrupted plasma membrane. After 2 DIV, 59.2 ± 2.5% of cells (n=3 preparations) were viable as indicated by the absence of nuclear staining.
To determine whether the selected cells were neurons, we performed immunocytochemical stainings (n=6) using antibodies against cell type-specific marker proteins, including neurofilament 200 (neurons), GFAP (astrocytes), O4 (oligodendrocytes), and fibronectin (nonneural cells). Nuclei were labeled by Hoechst 33342. As positive controls, we also cultured and stained cells that were nonadherent in the L1-immunoisolation on PDL-and laminin-coated dishes. After 2 DIV, the vast majority of these control cells were positive for fibronectin. Neurofilament-positive neurons and GFAP-positive astrocytes with typical morphologies were frequently detected, as described previously for dissociated EBs (7, 8) (Fig. 2A) . However, no O4-positive cells were found. Strikingly, in the L1-selected cell population, the surviving cells were almost exclusively neurofilament 200-positive (93.4±3.4%) and showed a clear neuronal morphology (Fig. 2C, 2D ). No fibronectin-or O4-positive cells were found. A small fraction of cells (6.4±1.1%) was positive for GFAP but interestingly did not show a typical astrocytic morphology (Fig. 2C ). These results demonstrate that our procedure enables a highly efficient purification of neuronally differentiated ES cells. The few GFAP-positive cells presumably represent neuronal precursors, which have been shown to express this astrocyte marker (20) .
We next studied whether the L1-selected cells expressed key functional properties of neurons, that is, electrical excitability and formation of synapses. To accomplish this, we performed electrophysiological recordings on L1-selected cells that were long-term cultured on microislands of glial cells (18) (Fig. 3A) . After 10-12 DIV, each ES cell-derived neuron tested (n=29) fired TTX-sensitive action potentials upon depolarization by current injection (Fig. 3B) . To demonstrate the presence of synaptic specializations, we performed immunocytochemical stainings with a polyclonal antibody against the synaptic vesicle protein synapsin I. These stainings revealed a large number of presynaptic boutons on the soma and on the dendrites (12.9±1.1 per 50 µm dendrite; n=15) of ES cell-derived neurons after 10 DIV (Fig. 3C ).
To electrophysiologically determine whether these synapses were functional, we recorded miniature postsynaptic currents (mPSCs) that are caused by spontaneous, action potentialindependent fusion of single synaptic vesicles. Both inhibitory GABAergic and excitatory glutamatergic synapses were present after 11-13 DIV in microisland culture. GABA A receptormediated mPSCs were observed at a mean frequency of 0.5 ± 0.1 Hz (n=11; mean amplitude, 11±2 pA) and were reversibly blocked by bicuculline (25 µM, n=3) (Fig. 3E) . Similarly, non-NMDA (AMPA/kainate) receptor-mediated mPSCs were observed at a mean frequency of 1.7 ± 0.4 Hz (n=5; mean amplitude, 12±1 pA) and were reversibly blocked by DNQX (10 µM, n=3) (Fig. 3D) . To test for the presence of NMDA receptors at glutamatergic synapses, we performed paired recordings (n=8) from pre-and postsynaptic neurons. Postsynaptic responses were evoked by eliciting action potentials in the presynaptic neurons. At a strongly negative holding potential (-60 mV), the fast-decaying PSCs were mediated exclusively by AMPA receptors (completely blocked by 10 µM DNQX or 100 µM SYM2206). Intriguingly, upon depolarization to +40mV, an additional, much more slowly decaying, and Mg 2+ -sensitive PSC component became apparent, indicating the presence of NMDA receptors (Fig. 3F) . NMDA receptor-mediated PSC components at +40 mV were blocked by MK-801 (40 µM). Thus, neuronally differentiated ES cells that were purified by L1-immunoisolation formed functional glutamatergic and GABAergic synapses with basic properties similar to primary cultured cortical neurons (18, 19, 21) .
Future therapeutic applications of stem cell-derived neurons require a purification step to ensure the absence of undifferentiated cells that may lead to tumor formation after transplantation. Here, we have developed an efficient immunoisolation method that allows the purification of large numbers of neurons. In coculture with glial cells, purified ES cell-derived neurons showed typical neuronal features, including electrical excitability and the formation of functional synapses. This new procedure to separate ES cell-derived neurons from nonneuronal and undifferentiated cells will strongly reduce the risk for side effects in transplantation studies. In principle, immunoisolation based on endogenous markers could also be extended to purify other stem cell-derived cell types without the need for genetic modification. 
